Literature DB >> 8743830

Bilateral primary seminal vesicle carcinoma.

A H Ormsby1, R Haskell, S E Ruthven, G E Mylne.   

Abstract

We report a rare case of bilateral primary seminal vesicle carcinoma in a 73 yr old Australian man. To our knowledge this case report is the 48th histologically confirmed case of primary seminal vesicle neoplasia and only the fourth reported case of primary bilateral seminal vesicle carcinoma. Macroscopically the tumor was localized to both seminal vesicles and the adjacent right lobe of the prostate. Histologically the tumor and metastases displayed a PSA, PAP and CEA negative, well differentiated papillary adenocarcinoma resembling the pattern of normal seminal vesicle epithelium. No other primary carcinoma in the body was demonstrated. The patient survived for 3 yrs and 4 mths without recurrence of tumor. The pathological criteria for acceptance of primary seminal vesicle carcinoma, difficulties in clinical/radiological detection of seminal vesicle tumors and CA-125 immunoreactivity are discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8743830     DOI: 10.1080/00313029600169883

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  4 in total

1.  [A primary adenocarcinoma of the seminal vesicles. Case report of a rare malignancy].

Authors:  C Möhring; P Bach; S Kosciesza; M Goepel
Journal:  Urologe A       Date:  2008-05       Impact factor: 0.639

2.  Metastatic primary seminal vesicle adenocarcinoma: management of a rare tumour with multiagent chemotherapy and hormonal therapy.

Authors:  Hira Lal; Priyank Yadav; Rahul Jena; Manoj Jain
Journal:  BMJ Case Rep       Date:  2017-10-10

3.  Congenital anomalies of the genitourinary system can help in diagnosis of the primary site of metastatic cancer: a case report and a review of the literature.

Authors:  Andrzej Deptala; Agnieszka Romanowicz; Aleksandra Czerw; Jerzy Walecki; Wojciech Rogowski; Anna Nasierowska-Guttmejer
Journal:  Onco Targets Ther       Date:  2016-07-20       Impact factor: 4.147

4.  A 5-year follow-up of primary seminal vesicle adenocarcinoma: A case report.

Authors:  Tiejun Yin; Yueqiang Jiang
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.